Glory Health Industry Limited submitted its monthly return to Hong Kong Exchanges and Clearing on 8 April 2026, indicating no changes in share capital for the month ended 31 March 2026.

The company’s authorised share capital remained at 10.00 million Hong Kong dollars, corresponding to 10 billion ordinary shares with a par value of HKD 0.001 each.

Issued share capital was unchanged at 4.44 billion ordinary shares, and the company continued to hold zero treasury shares.

Glory Health confirmed that it met the minimum 15% public-float requirement prescribed at the time of listing, satisfying Main Board Rule 13.32D(1).

No share options, warrants, convertible instruments, Hong Kong depositary receipts, or other equity-linked arrangements were issued, exercised, or cancelled during the month.

The unchanged figures underscore a stable capital structure for Glory Health through March 2026.